|
Dr. O'Donnell has served as Chairman of the Board of Accentia Biopharmaceuticals since November, 1998 and as CEO since May 2003. Dr O'Donnell is a 1975, summa cum laude graduate of the Johns Hopkins School of Medicine. He received his specialty training at the Wilmer Ophthalmological Institute, Johns Hopkins Hospital. He is the former Professor and Chairman, Dept of Ophthalmology, St Louis University School of Medicine. He is the Founder and Managing Partner of The Hopkins Capital Group (HCG), LLC, a leading biotech investment/business development company. The HCG specializes in early-stage investments in disruptive innovations in healthcare. Dr O'Donnell has published over 30 peer-reviewed scientific articles and he has been awarded 34 US Patents. He is the recipient of the 2000 Jules Stein Award from Retinitis Pigmentosa International. | 